3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
9
Esophageal Squamous Cell Carcinoma
5
Neoplasm Metastasis
4
Carcinoma, Hepatocellular
4
Advanced Solid Tumors
4
Recurrence
3
Colorectal Neoplasms
3
Stomach Neoplasms
2
Small Cell Lung Carcinoma
2
Neoplasms
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma
2
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Solid Tumors
1
Sarcoma
1
Neuroendocrine Tumors
1
Nasopharyngeal Neoplasms
1
Melanoma
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, T-Cell
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Follicular
1
Lymphoma, Extranodal NK-T-Cell
1
Lymphoma, B-Cell, Marginal Zone
1
Lung Neoplasms
1
Locally Advanced or Metastatic Urothelial Bladder Cancer
1
Interventions
Fluorouracil
8
Radiotherapy
4
Mitomycin
4
Cyclophosphamide
3
Cisplatin
3
pembrolizumab
2
fludarabine phosphate
2
fludarabine
2
aldesleukin
2
Watchful Waiting
2
VGX-3100
2
Specimen Handling
2
Papillomavirus Vaccines
2
Nivolumab
2
Magnetic Resonance Spectroscopy
2
Light Coagulation
2
Ipilimumab
2
Cetuximab
2
CTLA-4 Antigen
2
Biopsy
2
tempol
1
rocakinogene sifuplasmid
1
enzalutamide
1
durvalumab
1
dehydroftorafur
1
alovudine
1
abiraterone
1
Yoga
1
Therapeutics
1
SRA737
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Anus Neoplasms
×
tislelizumab
×
Clear all
No trials found.